Skip to main content

Table 1 Patients' demographic data, clinical characteristics, and survival

From: Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock

Demographic data

 

   Age in years, median (range)

52 (25 to 73)

   Female/male, number

10/10

Septic shock: reasons

 

   Pneumonia

8

   Urosepsis

4

   Cholangitis

4

   Endocarditis

3

   Catheter-associated

3

Pathogen

 

   Staphylococcus epidermidis, number

6

   Staphylococcus aureus, number

2

   Haemophilus influenca, number

4

   Enterococcus faecalis, number

3

   Escherichia coli, number

3

   Pseudomonas aeruginosa, number

2

Severity-of-illness scores

 

   APACHE II score, median (range)

30 (18 to 52)

   SAPS II, median (range)

42 (32 to 66)

Catecholamine therapy

 

Dobutamine, number

Dose in μg/kg per minute (mean ± SD)

20

(6.4 ± 2.9)

Norepinephrine, number

Dose in μg/kg per minute (mean ± SD)

16

(0.2 ± 0.2)

Outcome

 

   ICU mortality rate, number (percentage)

4 (20)

   Hospital mortality rate, number (percentage)

5 (25)

  1. APACHE, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit; SAPS, Simplified Acute Physiology Score; SD, standard deviation.